301 related articles for article (PubMed ID: 8664605)
1. [The rational computer-aided design of new drugs: a review of the methods].
Ivanov AS; Liul'kin IuA; Skvortsov VS; Rumiantsev AB
Vestn Ross Akad Med Nauk; 1995; (12):51-6. PubMed ID: 8664605
[TBL] [Abstract][Full Text] [Related]
2. Role of computer-aided drug design in modern drug discovery.
Macalino SJ; Gosu V; Hong S; Choi S
Arch Pharm Res; 2015 Sep; 38(9):1686-701. PubMed ID: 26208641
[TBL] [Abstract][Full Text] [Related]
3. [The rational computer-aided design of new drugs].
Archakov AI; Ivanov AS
Vestn Ross Akad Med Nauk; 1996; (1):60-3. PubMed ID: 8907430
[TBL] [Abstract][Full Text] [Related]
4. Advances in modeling of biomolecular interactions.
Cai CZ; Li ZR; Wang WL; Chen YZ
Acta Pharmacol Sin; 2004 Jan; 25(1):1-8. PubMed ID: 14704115
[TBL] [Abstract][Full Text] [Related]
5. [Computer-designed site-specific drugs--myth or reality?].
Taskinen J
Duodecim; 1995; 111(8):799-806. PubMed ID: 8681840
[No Abstract] [Full Text] [Related]
6. [An introduction to the computer-aided structure-based drug design--applications of bioinformatics to drug discovery].
Hirono S
Rinsho Byori; 2002 Jan; 50(1):45-51. PubMed ID: 11871136
[TBL] [Abstract][Full Text] [Related]
7. The use of protein-ligand interaction fingerprints in docking.
Brewerton SC
Curr Opin Drug Discov Devel; 2008 May; 11(3):356-64. PubMed ID: 18428089
[TBL] [Abstract][Full Text] [Related]
8. From drug target to leads--sketching a physicochemical pathway for lead molecule design in silico.
Shaikh SA; Jain T; Sandhu G; Latha N; Jayaram B
Curr Pharm Des; 2007; 13(34):3454-70. PubMed ID: 18220783
[TBL] [Abstract][Full Text] [Related]
9. Quantitative structure-activity relationship: promising advances in drug discovery platforms.
Wang T; Wu MB; Lin JP; Yang LR
Expert Opin Drug Discov; 2015 Dec; 10(12):1283-300. PubMed ID: 26358617
[TBL] [Abstract][Full Text] [Related]
10. Physics-based methods for studying protein-ligand interactions.
Huang N; Jacobson MP
Curr Opin Drug Discov Devel; 2007 May; 10(3):325-31. PubMed ID: 17554859
[TBL] [Abstract][Full Text] [Related]
11. 3D-QSAR and receptor modeling of tyrosine kinase inhibitors with flexible atom receptor model (FLARM).
Peng T; Pei J; Zhou J
J Chem Inf Comput Sci; 2003; 43(1):298-303. PubMed ID: 12546565
[TBL] [Abstract][Full Text] [Related]
12. Lead optimization via high-throughput molecular docking.
Joseph-McCarthy D; Baber JC; Feyfant E; Thompson DC; Humblet C
Curr Opin Drug Discov Devel; 2007 May; 10(3):264-74. PubMed ID: 17554852
[TBL] [Abstract][Full Text] [Related]
13. Development of quantitative structure-activity relationships and its application in rational drug design.
Yang GF; Huang X
Curr Pharm Des; 2006; 12(35):4601-11. PubMed ID: 17168765
[TBL] [Abstract][Full Text] [Related]
14. Ranking poses in structure-based lead discovery and optimization: current trends in scoring function development.
Rajamani R; Good AC
Curr Opin Drug Discov Devel; 2007 May; 10(3):308-15. PubMed ID: 17554857
[TBL] [Abstract][Full Text] [Related]
15. Virtual screening and rational drug design method using structure generation system based on 3D-QSAR and docking.
Chen HF; Dong XC; Zen BS; Gao K; Yuan SG; Panaye A; Doucet JP; Fan BT
SAR QSAR Environ Res; 2003 Aug; 14(4):251-64. PubMed ID: 14506869
[TBL] [Abstract][Full Text] [Related]
16. Importance of molecular computer modeling in anticancer drug development.
Geromichalos GD
J BUON; 2007 Sep; 12 Suppl 1():S101-18. PubMed ID: 17935268
[TBL] [Abstract][Full Text] [Related]
17. Structure-based drug design and modern medicine.
Vijayakrishnan R
J Postgrad Med; 2009; 55(4):301-4. PubMed ID: 20083886
[TBL] [Abstract][Full Text] [Related]
18. Designing better drugs: predicting cytochrome P450 metabolism.
de Groot MJ
Drug Discov Today; 2006 Jul; 11(13-14):601-6. PubMed ID: 16793528
[TBL] [Abstract][Full Text] [Related]
19. Computer-aided Drug Design and Drug Pharmacokinetic Prediction: A Mini-review.
Tabeshpour J; Sahebkar A; Zirak MR; Zeinali M; Hashemzaei M; Rakhshani S; Rakhshani S
Curr Pharm Des; 2018; 24(26):3014-3019. PubMed ID: 30179125
[TBL] [Abstract][Full Text] [Related]
20. Recent developments in de novo design and scaffold hopping.
Mauser H; Guba W
Curr Opin Drug Discov Devel; 2008 May; 11(3):365-74. PubMed ID: 18428090
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
